(HealthDay News) — Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published in JAMA Oncology.

Alopecia areata is an autoimmune disorder that causes hair loss in patches on the scalp and other areas of the body. Coping with this condition can be challenging, especially when it comes to ...

She was diagnosed with alopecia areata, an autoimmune condition that disrupts regular hair growth, at just 18 months old and ...

I am a healthy 23-year-old woman. I started noticing extra hairs in my brush, and then my mom found two bald spots on the back of my head. I did a telehealth appointment and they said it’s alopecia ...

Adapted from a talk to The SLE Workshop at Hospital for Special Surgery By Charis F. Meng, MD Acupuncture dates back at least 2,500 years. It is based on traditional Chinese medicine (TCM), which ...

This content was created by our physicians and experts. Acupuncture is an ancient form of healing in traditional Chinese medicine. Although the practice predates recorded history, evidence suggests ...

Diffuse androgenetic alopecia (female pattern hair loss), telogen effluvium, and diffuse alopecia areata may have similar clinical manifestations. Subtle details on physical examination and dermoscopy ...

"Today's approval will help fulfill a significant unmet need for patients with severe alopecia areata." Alopecia areata is an autoimmune disorder in which the body attacks its own hair follicles, ...

Introduction There is a lack of curative medical treatment for patients with knee osteoarthritis (KOA). Acupuncture represents an important alternative therapy. According to the theory of traditional ...

Sensory stimulation via acupuncture has been reported to alter activities of numerous neural systems by activating multiple efferent pathways. Acupuncture has been widely used to treat patients with ...

School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China ...

The trial of HCW9302, which is designed to activate and expand regulatory T cells, is set to evaluate patients with moderate to severe alopecia areata from the third quarter of the year.